BCAL(BCAL)
BCAL
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $182M | $194M |
| Low | $182M | $192M |
| High | $183M | $196M |
| EBITDA Avg | $87M | $92M |
| Low | $86M | $91M |
| High | $87M | $93M |
| EBIT Avg | $83M | $88M |
| Low | $82M | $87M |
| High | $83M | $89M |
| Net Income Avg | $57M | $61M |
| Low | $56M | $60M |
| High | $58M | $61M |
| EPS Avg | $1.74 | $1.85 |
| Low | $1.72 | $1.83 |
| High | $1.76 | $1.87 |
| Analysts (Rev / EPS) | 3 / 2 | 3 / 2 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $46M | $47M | $47M | $48M | $49M | $50M |
| Low | $46M | $47M | $46M | $48M | $49M | $49M |
| High | $46M | $48M | $47M | $48M | $50M | $50M |
| EBITDA Avg | $22M | $22M | $22M | $23M | $23M | $24M |
| Low | $22M | $22M | $22M | $23M | $23M | $23M |
| High | $22M | $23M | $22M | $23M | $24M | $24M |
| EBIT Avg | $21M | $21M | $21M | $22M | $22M | $23M |
| Low | $21M | $21M | $21M | $21M | $22M | $22M |
| High | $21M | $22M | $21M | $22M | $22M | $23M |
| Net Income Avg | $14M | $14M | $14M | $15M | $15M | $16M |
| Low | $14M | $14M | $14M | $15M | $15M | $16M |
| High | $14M | $15M | $14M | $15M | $16M | $16M |
| EPS Avg | $0.43 | $0.44 | $0.43 | $0.46 | $0.47 | $0.48 |
| Low | $0.43 | $0.43 | $0.43 | $0.45 | $0.47 | $0.48 |
| High | $0.44 | $0.45 | $0.44 | $0.46 | $0.48 | $0.49 |
| Analysts (Rev / EPS) | 3 / 2 | 3 / 3 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |